BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang ZH, Jiang PH, Li NJ, Shi M, Huang W. Oral vaccination of mice against rodent malaria with recombinant Lactococcus lactis expressing MSP-119World J Gastroenterol 2005; 11(44): 6975-6980 [PMID: 16437602 DOI: 10.3748/wjg.v11.i44.6975]
URL: https://www.wjgnet.com/1007-9327/full/v11/i44/6975.htm
Number Citing Articles
1
Luis G. Bermúdez-Humarán, Philippe Langella. Utilisation des bactéries lactiques comme vecteurs vaccinauxRevue Francophone des Laboratoires 2009; 2009(417): 79 doi: 10.1016/S1773-035X(09)70312-0
2
Sakineh Pirahmadi, Shima Afzali, Mostafa Zargar, Sedigheh Zakeri, Akram Abouie Mehrizi. How can we develop an effective subunit vaccine to achieve successful malaria eradication?Microbial Pathogenesis 2021; 160: 105203 doi: 10.1016/j.micpath.2021.105203
3
G. Moorthy, R. Ramasamy. Mucosal immunisation of mice with malaria protein on lactic acid bacterial cell wallsVaccine 2007; 25(18): 3636 doi: 10.1016/j.vaccine.2007.01.070
4
Miguel P. Soares, Bahtiyar Yilmaz. Microbiota Control of Malaria TransmissionTrends in Parasitology 2016; 32(2): 120 doi: 10.1016/j.pt.2015.11.004
5
Pavel Yu Pechenov, Danil A. Garagulya, Daniil S. Stanovov, Andrey V. Letarov. New Effective Method of Lactococcus Genome Editing Using Guide RNA-Directed TranspositionInternational Journal of Molecular Sciences 2022; 23(22): 13978 doi: 10.3390/ijms232213978
6
Zhisheng Wang, Junkai Gao, Qinghua Yu, Qian Yang. Oral immunization with recombinant Lactococcus lactis expressing the hemagglutinin of the avian influenza virus induces mucosal and systemic immune responsesFuture Microbiology 2012; 7(8): 1003 doi: 10.2217/fmb.12.69
7
Lina Wang, Ross L Coppel. Oral vaccine delivery: can it protect against non-mucosal pathogens?Expert Review of Vaccines 2008; 7(6): 729 doi: 10.1586/14760584.7.6.729
8
Hans Van der Weken, Eric Cox, Bert Devriendt. Advances in Oral Subunit Vaccine DesignVaccines 2020; 9(1): 1 doi: 10.3390/vaccines9010001
9
N. Mojgani, Y. Shahali, M. Dadar. Immune modulatory capacity of probiotic lactic acid bacteria and applications in vaccine developmentBeneficial Microbes 2020; 11(3): 213 doi: 10.3920/BM2019.0121
10
Olivia Cano-Garrido, Joaquin Seras-Franzoso, Elena Garcia-Fruitós. Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposesMicrobial Cell Factories 2015; 14(1) doi: 10.1186/s12934-015-0313-6
11
Luis G Bermúdez-Humarán, Pascale Kharrat, Jean-Marc Chatel, Philippe Langella. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccinesMicrobial Cell Factories 2011; 10(S1) doi: 10.1186/1475-2859-10-S1-S4
12
Karen K. Yam, Philippe Pouliot, Marie M. N’diaye, Sylvie Fournier, Martin Olivier, Benoit Cousineau. Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactisVaccine 2008; 26(22): 2689 doi: 10.1016/j.vaccine.2008.03.024
13
Jerry Wells. Mucosal Vaccination and Therapy with Genetically Modified Lactic Acid BacteriaAnnual Review of Food Science and Technology 2011; 2(1): 423 doi: 10.1146/annurev-food-022510-133640
14
Jerry M. Wells, Annick Mercenier. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteriaNature Reviews Microbiology 2008; 6(5): 349 doi: 10.1038/nrmicro1840
15
Amino V.A. Kusuma, Apon Z. Mustopa, Wike Z. Mustafawi, Suharsono Suharsono. The production of SPusp45-MSP-1<sub>19</sub> gene construct and its recombinant protein in <em>Lactococcus lactis</em> to be used as a malaria vaccineMedical Journal of Indonesia 2018; 26(4): 261 doi: 10.13181/mji.v26i4.2162
16
Mohammed Bahey-El-Din, Pat G. Casey, Brendan T. Griffin, Cormac G.M. Gahan. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8+ T cells against Listeria monocytogenes in the murine infection modelVaccine 2008; 26(41): 5304 doi: 10.1016/j.vaccine.2008.07.047
17
Adrian C.N. Sim, Wenwei Lin, Grace K.X. Tan, Magenta S.T. Sim, Vincent T.K. Chow, Sylvie Alonso. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigenVaccine 2008; 26(9): 1145 doi: 10.1016/j.vaccine.2007.12.047
18
Beatriz del Rio, Begoña Redruello, Maria Fernandez, M. Cruz Martin, Victor Ladero, Miguel A. Alvarez. Lactic Acid Bacteria as a Live Delivery System for the in situ Production of Nanobodies in the Human Gastrointestinal TractFrontiers in Microbiology 2019; 9 doi: 10.3389/fmicb.2018.03179
19
Luis G. Bermúdez-Humarán, Silvia Innocentin, Francois Lefèvre, Jean-Marc Chatel, Philippe Langella. Prebiotics and Probiotics Science and Technology2009; : 1099 doi: 10.1007/978-0-387-79058-9_29
20
E. Elsa Herdiana Murhandarwati, Lina Wang, Harini D. de Silva, Charles Ma, Magdalena Plebanski, Casilda G. Black, Ross L. Coppel. Growth-Inhibitory Antibodies Are Not Necessary for Protective Immunity to Malaria InfectionInfection and Immunity 2010; 78(2): 680 doi: 10.1128/IAI.00939-09
21
Shirin Tarahomjoo. Development of Vaccine Delivery Vehicles Based on Lactic Acid BacteriaMolecular Biotechnology 2012; 51(2): 183 doi: 10.1007/s12033-011-9450-2
22
A. Mofredj, H. Bahloul, C. Chanut. Lactococcus lactis: un pathogène opportuniste?Médecine et Maladies Infectieuses 2007; 37(4): 200 doi: 10.1016/j.medmal.2007.01.005
23
Maryam Dadar, Youcef Shahali, Naheed Mojgani. Probiotic Bacteria and Postbiotic Metabolites: Role in Animal and Human HealthMicroorganisms for Sustainability 2021; 2: 319 doi: 10.1007/978-981-16-0223-8_13
24
Tracy Saveria, Chaitra Parthiban, Annette M. Seilie, Colin Brady, Anissa Martinez, Ridhima Manocha, Esha Afreen, Hui Zhao, Ashley Krzeszowski, Jeremy Ferrara, Troy Paddock, James Roberts, Brad C. Stone, Michael Tasch, Sean C. Murphy. Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in micenpj Vaccines 2022; 7(1) doi: 10.1038/s41541-022-00534-5
25
Haiqin Chen, Chen Chen, Chunqing Ai, Chengcheng Ren, He Gao. Lactic Acid Bacteria2019; : 35 doi: 10.1007/978-981-13-7832-4_2